Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy
NCT03710356
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Telomere Shortening
Telomere Length, Mean Leukocyte
Interventions
DRUG:
Danazol 200 MG
Sponsor
Assistance Publique - Hôpitaux de Paris